ENVX

Enovix Corp

Add to Watchlist

Advanced Chart

10.780

-0.22(-2.000%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

11.310

Open

11.085

VWAP

10.85

Vol

4.61M

Mkt Cap

2.12B

Low

10.630

Amount

50.00M

EV/EBITDA(TTM)

Total Shares

170.00M

2.10B

EV/OCF(TTM)

P/S(TTM)

76.57

Enovix Corporation is a global high-performance battery company. The Company designs, develops, manufactures, and commercializes lithium-ion (Li-ion) battery cells that increase the amount of energy density and storage capacity relative to conventional battery cells. In addition to designing its batteries, it also develops the advanced manufacturing processes needed to produce its batteries in high volume. It targets a smaller group of large customers that require custom cells. Its technology roadmap is built around a structured progression of battery nodes, with each new generation, such as the EX-1M, EX-2M, EX-3M and so on. The Company, through Routejade, Inc. (Routejade), supplies batteries for wearables, medical devices, headsets, activity trackers, and industrial equipment. Routejade offers product categories, including PD series, FLPB and ASDB series, and SLPB series. The PD series consists of rechargeable coin cells commonly used in healthcare and IoT applications.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

14.93M

+192.88%

12.25M

+26.1%

7.93M

+83.6%

Estimates Revision

The market is revising Downward the revenue expectations for Enovix Corporation (ENVX) for FY2025, with the revenue forecasts being adjusted by -9.76% over the past three months. During the same period, the stock price has changed by 44.12%.

Revenue Estimates for FY2025

Revise Downward

-9.76%

In Past 3 Month

Stock Price

Go Up

+44.12%

In Past 3 Month

9 Analyst Rating

91.37% Upside

Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is 20.63 USD with a low forecast of 12.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

2 Hold

0 Sell

Strong Buy

91.37% Upside

Current: 10.780

Low

12.00

Averages

20.63

High

33.00

91.37% Upside

Current: 10.780

Low

12.00

Averages

20.63

High

33.00

Canaccord

Buy

maintain

$20 -> $22

2025-08-04

Reason

Canaccord

Price Target

$20 -> $22

2025-08-04

maintain

Buy

Reason

Canaccord raised the firm's price target on Enovix to $22 from $20 and keeps a Buy rating on the shares. The firm said its target raise is based on an improved ASP outlook and other adjustments to our model following its capital raise plan through a "warrant dividend" and a positive pre-announcement and after Enovix had their official 2Q25 earnings call.

Oppenheimer

Outperform

maintain

$36 -> $33

2025-08-01

Reason

Oppenheimer

Price Target

$36 -> $33

2025-08-01

maintain

Outperform

Reason

Oppenheimer lowered the firm's price target on Enovix to $33 from $36 and keeps an Outperform rating on the shares. As Enovix moves toward scaling Fab 2 and design-ins with multiple customers, the firm is encouraged to see the company preparing for incremental capacity expansion and ordering long-lead-time items. Oppenheimer also believes the detailed customer conversations and sharing of specs are crucial for Enovix to continue evolving its product roadmap effectively.

Craig-Hallum

Buy

upgrade

$15 -> $16

2025-08-01

Reason

Craig-Hallum

Price Target

$15 -> $16

2025-08-01

upgrade

Buy

Reason

Craig-Hallum raised the firm's price target on Enovix to $16 from $15 and keeps a Buy rating on the shares. The firm believes the company is positioned well to scale production as smartphone battery requirements continue to increase. Enovix is working with 7/8 top smartphone OEMs by volume and is currently sampling with two major smartphone OEMs. Craig-Hallum highlights Enovix's current results continue to benefit from stronger, higher margin, defense business out of Korea.

Benchmark

NULL

Buy

upgrade

$15 -> $25

2025-07-25

Reason

Benchmark

Price Target

$15 -> $25

2025-07-25

upgrade

NULL

Buy

Reason

Benchmark raised the firm's price target on Enovix to $25 from $15 and keeps a Buy rating on the shares. Enovix released preliminary Q2 results on July 7 and is scheduled to report full Q2 earnings after the close on Thursday, July 31, notes the analyst, who cites recent execution and the strategic significance of the AI-1 platform for the firm's increased price target.

JPMorgan

Bill Peterson

Overweight -> Neutral

downgrade

$9 -> $12

2025-07-24

Reason

JPMorgan

Bill Peterson

Price Target

$9 -> $12

2025-07-24

downgrade

Overweight -> Neutral

Reason

JPMorgan analyst Bill Peterson downgraded Enovix to Neutral from Overweight with a price target of $12, up from $9, which implies 18% downside from current levels. The firm citers valuation for the downgrade with the shares up 91% since President Trump's "Liberation Day." While Enovix should benefit from the recent "risk-on environment" and its capital allocation decision announcement, the current valuation is "rich" as its success is already priced in, the analyst tells investors in a research note.

B. Riley

Buy

maintain

$12 -> $17

2025-07-10

Reason

B. Riley

Price Target

$12 -> $17

2025-07-10

maintain

Buy

Reason

B. Riley raised the firm's price target on Enovix to $17 from $12 and keeps a Buy rating on the shares. The firm cites the company's "flurry of recent positive updates" for the target increase. Enovix announced preliminary Q2 results that beat expectations, launched a silicon-anode smartphone battery platform, and declared a shareholder warrant dividend that could raise up to $253.8M, the analyst tells investors in a research note.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Enovix Corp (ENVX.O) is -13.14, compared to its 5-year average forward P/E of -14.91. For a more detailed relative valuation and DCF analysis to assess Enovix Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-14.91

Current PE

-13.14

Overvalued PE

-4.17

Undervalued PE

-25.66

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-19.50

Current EV/EBITDA

-24.22

Overvalued EV/EBITDA

-8.99

Undervalued EV/EBITDA

-30.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

319.93

Current PS

38.48

Overvalued PS

590.32

Undervalued PS

49.54